Ranibizumab for Predominantly Classic Neovascular Age-related Macular Degeneration: Subgroup Analysis of First-year ANCHOR Results

Authors:
  • DBDavid M. Brown
    David M. Brown
  • KZKang Zhang
    Kang Zhang
  • HHHenry L. Hudson
    Henry L. Hudson
  • FHFrank G. Holz
    Frank G. Holz
  • HSHoward Shapiro
    Howard Shapiro
  • SSSusan Schneider
    Susan Schneider
  • NANisha R. Acharya
    Nisha R. Acharya

Abstract
No abstract available